4CD9

4CD9 is a chemical compound with the molecular formula C17H14N2O. It is a derivative of a purine base and is notable for its interaction with certain biological targets. Specifically, it has been identified as an inhibitor of the enzyme phosphodiesterase 4 (PDE4). PDE4 enzymes play a crucial role in cellular signaling pathways, particularly in the regulation of cyclic adenosine monophosphate (cAMP) levels. By inhibiting PDE4, 4CD9 can increase intracellular cAMP concentrations.

The modulation of cAMP levels has implications in various physiological processes, including inflammation and immune responses. Consequently, compounds like 4CD9 have been explored for their potential therapeutic applications, particularly in inflammatory diseases. Research into 4CD9 has focused on understanding its binding affinity to PDE4 subtypes, its pharmacokinetic properties, and its efficacy in preclinical models of inflammation. While it has demonstrated inhibitory activity, further research is typically required to establish its safety and effectiveness for human use. The specific three-dimensional structure of 4CD9 in complex with its target enzyme has also been a subject of study to facilitate rational drug design.